Cracking the Mysterious Neurological Disorders at OMICS International Conferences

Share Article

OMICS International is making remarkable efforts by focusing on major neurological disorders of the globe through its International Neuroscience conferences by shedding light on mysterious brain and neurological diseases, enhancing our understanding.

OMICS International

Meet Inspiring Speakers at 1000+ OMICS International Global Events on Pharma, Medicine, Science and Technology during 2015

Neurology conferences focus on current and advanced strategies, with a view to face the upcoming challenges in the field of Neurology including Dementia, Brain Disorders, Psychiatry, Child Psychology and Stroke. Neurosciences have transformed our understanding of the healthy brain and promises treatments for devastating disorders that affect millions of people. The scope of neuroscience has broadened to include different approaches used to study the molecular, functional, developmental, structural, computational, and medical aspects of the nervous system.

Mental illness affects people of all ages having a significant impact on many young people. About 27% of the adult population had experienced at least one serious mental disorder which includes problems arising from psychosis, substance use, depression, eating disorders and anxiety. Whereas the Stress and sleep disorders are evolutionary-conserved physiological response to threatening and adverse environments. OMICS Global Neuroscience conferences are designed to address challenges pertaining to discuss the problems aforementioned.

Brain injuries are often caused by brain trauma. Injury can damage tissue, neurons and nerves. This can cause changes in how brain communicates with the rest of your body. Some brain diseases, such as Alzheimer’s disease, may manifest during aging process and slowly impair memory and thought processes. There are approximately 500,000 people dying each year because they have Alzheimer's and it was also recorder that about 1% of people worldwide have epilepsy characterized with seizures.

Parkinson’s is estimated to affect up to 160 per 100,000 of the general population. Even though a new era in the history of Parkinson’s disease started with the discovery of levodopa and dopamine-supporting drugs more than half a century ago, leading to dramatic improvements in the patients quality of life and longevity, the situation for a Parkinson patient is still far from satisfactory, demanding further research in this area.

OMICS Group is organizing more than 1000 scientific events every year across USA, Europe, Middle East and Asia. These conferences create a venue to connect and share recent research, knowledge and development in various fields, involving established researchers, scientists, entrepreneurs and students. B2B and Scientific meetings organized by us are excellent platform for networking and business development.

OMICS International has an enhanced and highlighted feature of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research all around the globe It has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care through more than 500 leading-edged, Peer reviewed, Open Access Journals. These journals have over 5 million readers and backup of 30000 eminent personalities providing rapid, quality and quick reviews.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Issac Samuel

Valentina Cooper
OMICS Group International Conferences
Like >
Follow us on
Visit website